The following is an analysis of the stock option grant activity (Details) - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
Equity [Abstract] | ||
Number Outstanding December 31, 2023 | 870,449 | 197,560 |
Weighted- Average Exercise Price Outstanding December 31, 2023 | $ 5.85 | $ 22.68 |
Outstanding December 31, 2023 | 9 years 29 days | 9 years 9 months 3 days |
Number Granted | ||
Weighted- Average Exercise Price Granted | ||
Number Expired | ||
Weighted- Average Exercise Price Expired | ||
Number Exercised | ||
Weighted- Average Exercise Price Exercised | ||
Number Outstanding March 31, 2024 | 870,449 | 197,560 |
Weighted- Average Exercise Price Outstanding March 31, 2024 | $ 5.85 | $ 22.68 |
Outstanding March 31, 2024 | 9 years 4 months 24 days | 9 years 3 months 26 days |
Number Exercisable March 31, 2024 | 409,679 | 127,723 |
Weighted- Average Exercise Price Exercisable March 31, 2024 | $ 9.60 | $ 22.68 |
Exercisable March 31, 2024 | 8 years 10 months 14 days | 9 years 2 months 12 days |
Granted | 10 years | |
Weighted- Average Exercise Price Expired |
X | ||||||||||
- Definition The element represents share based compensation arrangement by share based payment award options granted in period weighted average remaining life. No definition available.
|
X | ||||||||||
- Definition The element represents weighted average remaining life end. No definition available.
|
X | ||||||||||
- Definition The element represents weighted average remaining life start. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|